Thermo Fisher Scientific (NYSE:TMO) pushed up Monday on news of their Dionex (Nasdaq:DNEX) bid..
Auriga said, "DNEX has expanded its presence in China and India, and that both regions remain a key source of growth. DNEX's customers in emerging markets are generally "green field" opportunities -- as they have limited installed base or legacy equipment in house. As such, customers are often more open (or able) to exploring new product platforms."
DNEX had sales of $420 million for full year 2010, with 30 percent coming from HPLC and 70 percent from IC.
EPS estimates from Auriga for Thermo Fisher for full year 2011 are kept in place at $4.15.
Thermo Fisher closed Monday at $55.56, up $2.52, or 4.75 percent. Auriga has a price target of $66 on them.
Tuesday, December 14, 2010
Thermo Fisher (NYSE:TMO) Up on Dionex (Nasdaq:DNEX) Bid
Labels:
Auriga,
Dionex,
Thermo Fisher Scientific
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment